You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
This page location is:
Lab Test Reference Manual
Human Reference Manual
Pages
22212
Lab Test Reference Manual
Human Reference Manual
Currently selected
22212
Alpha-1 Antitrypsin
Marshfield Lab Public WebSite
Marshfield Clinic Public WebSite
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Search
Test Code
Laboratory Section
All
Test Category
All
Browse By Test Name
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Additional Information
Libraries
Newsletter Document Library
Regional Menus Pages
Lists
Lab Clinical Practice Guidelines
Antimicrobial Susceptibility Panels
Toxicology Information
Urine Preservatives
Requisition Instructions
Testing
Newsletter Links
Newsletters 2014
Newsletters 2015
Newsletters 2016
Newsletters 2017
Newsletters 2018
Cumulative Antibiogram Reports
testz
Human Test Code IDs
Recent
Newsletters 2020
Site Contents
Alpha-1 Antitrypsin
Test Code: AAT
Overview
Ordering
Specimen
Performing
Clinical/Interpretive
Contacts
Coding
Synonyms/Keywords
Synonyms, Keywords
AAT, Alpha-1-antitrypsin, Alpha trypsin inhibitor, Alpha-1-protease inhibitor
Useful For
Useful For
The principle clinical interest in AAT levels is in detecting genetic deficiencies that lead to a form of emphysema. Proteolytic enzymes are released by bacteria and other inflammatory cells which are not inhibited and which cause tissue destruction in individuals with AAT deficiency. If decreased levels are found in individuals with pulmonary disease, genetic phenotyping using starch gel electrophoresis is frequently performed.
Specimen Requirements
Specimen Requirements
Fasting Required
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No
Serum
Red Top Tube
(RTT)
Serum Separator Tube (SST)
0.5 mL
0.4 mL
0.3 mL
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Serum
Refrigerate
7 days
Frozen
3 months
Rejection Criteria
Rejection Criteria
Plasma samples
Interference
Interference
Pregnancy and oral contraceptives may cause increase in Alpha-1 Antitrypsin
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
Monday through Friday
6-8 hours
Turbidimetric method/The Binding Site Optilite analyzer
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
95 - 190 mg/dL
Interpretation
Interpretations
Less than 80 mg/dL is considered clinically at risk for AAT deficiency. Follow-up AAT genotyping (AATGENO) is recommended.
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
82103
Synonyms/Keywords
Synonyms, Keywords
AAT, Alpha-1-antitrypsin, Alpha trypsin inhibitor, Alpha-1-protease inhibitor
Ordering Applications
Ordering Applications
Ordering Application
Description
Centricity
Alpha-1-Antitrypsin
Cerner
Alpha-1-Antitrypsin
COM
Alpha-1-Antitrypsin
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Requirements
Fasting Required
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No
Serum
Red Top Tube
(RTT)
Serum Separator Tube (SST)
0.5 mL
0.4 mL
0.3 mL
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Serum
Refrigerate
7 days
Frozen
3 months
Rejection Criteria
Rejection Criteria
Plasma samples
Interference
Interference
Pregnancy and oral contraceptives may cause increase in Alpha-1 Antitrypsin
Useful For
Useful For
The principle clinical interest in AAT levels is in detecting genetic deficiencies that lead to a form of emphysema. Proteolytic enzymes are released by bacteria and other inflammatory cells which are not inhibited and which cause tissue destruction in individuals with AAT deficiency. If decreased levels are found in individuals with pulmonary disease, genetic phenotyping using starch gel electrophoresis is frequently performed.
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
95 - 190 mg/dL
Interpretation
Interpretations
Less than 80 mg/dL is considered clinically at risk for AAT deficiency. Follow-up AAT genotyping (AATGENO) is recommended.
For more information visit:
http://labtestsonline.org
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
Monday through Friday
6-8 hours
Turbidimetric method/The Binding Site Optilite analyzer
For billing questions, see Contacts
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
82103
Return To Top
For most current information refer to the Marshfield Laboratory online reference manual.